The Ivd in Vitro Diagnostics Market size is expected to grow at an annual average of 2% during 2021-2027. In vitro diagnostics (IVD) is a medical device that requires the use of assays and reagents to diagnose a medical condition. Additionally, these instruments analyze samples of body fluids and tissues collected from patients. There are also many types of in vitro diagnostic devices that work with a variety of techniques such as immunodiagnosis, tissue diagnosis, hematology, and molecular diagnosis.
(Get 15% Discount on Buying this Report)
A full report of Ivd in Vitro Diagnostics Market is available at: https://www.orionmarketreports.com/ivd-in-vitro-diagnostics-market/37814/
The following segmentation are covered in this report:
By Application
- Infectious Diseases
- Cancer
- Cardiac Diseases
- Immune System Disorders
- Nephrological Diseases
- Gastrointestinal Diseases
- Others
By End User
- Standalone Laboratories
- Hospitals
- Academic & Medical Schools
- Point-of-Care
- Others
By Product & Service
- Reagents
- Instruments
- Software and Services
Company Profile
- Abbott
- Danaher
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Becton, Dickinson and Company
- Siemens Healthineers AG
- QIAGEN
- Quidel Corporation
- Hoffmann-La Roche AG
The report covers the following objectives:
- Proliferation and maturation of trade in the global Ivd in Vitro Diagnostics Market
- The market share of the global Ivd in Vitro Diagnostics Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Ivd in Vitro Diagnostics Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Ivd in Vitro Diagnostics Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
